In non-small-cell lung cancer (NSCLC), the expression of TIPE is downregulated via a decrease in EGFR levels and an increase in SNX (a key regulator of EGFR transporters) levels, which further inhibits ECL- and IGF-1-stimulated NSCLC cell migration (5). Here, IGF1 is linked to non-small cell lung carcinoma.